Scientists ’on brink of cure’ for superbug
The Independent, May 22, 2008
Scientists have developed a drug that they say could be cure for MRSA. A British research firm claims that their discovery represented a "major breakthrough" in the battle against MRSA, a superbug responsible for the deaths of more than 1,600 patients in the UK every year. The firm, Destiny Pharma, is already carrying out human trials on the drug, and hopes to make the drug available in hospitals within three years.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Don't Let Nurses Sink Your Bottom Line
- Hospitals Profit On Bloodstream Infections
- Fortunately, Angelina Jolie Isn't On Medicare
- Less Blood Testing for Some Surgeries Safe, Cost Effective
- Lower ED Margins Demand a Better Strategy
- How Chargemaster Data May Affect Hospital Revenue
- Primary Care Docs Average More Hospital Revenue Than Specialists
- ED Physicians Key to Half of Hospital Admissions
- House Lawmakers Grill CMS Over Health Exchange Navigators
